Hermetica Superfood Encyclopedia
Legacy index-continuity record: the score and narrative are provisional and must not be represented as validated or human-approved.
Review flags: AWAITING_SEMANTIC_VALIDATION
Safflower petals (Carthamus tinctorius) contain hydroxysafflor yellow A (HSYA) as the primary bioactive compound, which inhibits inflammation through PLCγ-PKC-IP3 pathway suppression and reduces TNF-α, IL-8, and MCP-1 release. The petals demonstrate antibacterial activity by disrupting bacterial protein synthesis and ATPase enzymes while providing cardiovascular protection through improved blood flow mechanisms.
Reported Benefits (Provisional)
Origin & History
Carthamus tinctorius, the safflower, is a thistle-like annual plant native to Central Asia, the Mediterranean, and parts of China and India. Its vibrant petals are prized in functional nutrition for their rich bioactive compounds that support cardiovascular and anti-inflammatory pathways.
Research Narrative (Provisional)
Emerging research, including in vitro and animal studies, suggests safflower petals possess cardiovascular, anti-inflammatory, and antioxidant properties. Studies highlight their potential to improve blood flow and reduce arterial stiffness, supporting their traditional uses.
Preparation & Dosage
Dosage guidance is withheld because the publication gate has not recorded adequate support for this profile.
Nutritional Profile
- Flavonoids: Carthamin, kaempferol - Polyphenols - Serotonin derivatives - Vitamin E - Iron - Magnesium
Reported Mechanism (Provisional)
Hydroxysafflor yellow A (HSYA) suppresses inflammatory cascades by inhibiting the PLCγ-PKC-IP3 pathway, blocking calcium flow and reducing pro-inflammatory cytokines TNF-α, IL-8, and MCP-1. The compound exhibits antitumor effects through JNK/P38 MAPK activation and NF-κB pathway inhibition, while downregulating PI3K/AKT signaling to decrease mTOR and Bcl-2 expression. Safflower yellow (SY) flavonoids inhibit tumor angiogenesis by reducing p38 MAPK phosphorylation and matrix metalloproteinases MMP-2/9.
Clinical Narrative (Provisional)
Current evidence is primarily limited to preclinical in vitro and animal studies, with no detailed human clinical trials reporting specific sample sizes or quantified endpoints. Laboratory studies demonstrate that 0.5% safflower extract inhibited Salmonella pullorum and E. coli growth, while acetone-water extracts yielded 15.09 mg GAE/g dry weight polyphenols with maximal antioxidant activity. HSYA showed statistically significant suppression of IL-1β-induced inflammatory markers in SW982 cell lines via ERK/NF-κB/AP-1 pathways. The evidence strength remains preliminary, requiring robust human clinical trials to validate therapeutic efficacy and establish dosing parameters.
Also Known As
Research updates — and 25% off your first order
Join our list for source-aware wellness education, review-state updates, and product news — and unlock 25% off your first Hermetica order. Educational content is not medical advice. No spam, unsubscribe anytime.